Stockholders' Equity - Summary of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Dec. 31, 2025 USD ($) $ / shares shares		Dec. 31, 2024 USD ($) $ / shares shares
Options
Options Outstanding, beginning balance | shares	1,177,862		1,158,530
Options, Grants | shares	30,000
Options, Exercises | shares	(222,183)		(230,668)
Options, Forfeitures | shares	(100,000)
Options Outstanding, ending balance | shares	885,679		927,862
Options, Nonvested | shares	173,333		5,000
Options, Exercisable | shares	712,346		922,862
Weighted Average Exercise Price Per Share
Weighted Average Exercise Price Per Share, Outstanding beginning balance	$ 9.68		$ 7.1
Weighted Average Exercise Price Per Share, Grants	20.57
Weighted Average Exercise Price Per Share, Exercised	8.3		14.23
Weighted Average Exercise Price Per Share, Forfeitures	25.24
Weighted Average Exercise Price Per Share, Outstanding ending balance	8.64		5.32
Weighted Average Exercise Price Per Share, Nonvested	24.59		39.69
Weighted Average Exercise Price Per Share, Exercisable	$ 4.76		$ 5.14
Aggregate Intrinsic Value, Outstanding beginning balance | $	$ 15,728		$ 29,354
Aggregate Intrinsic Value, Grants | $	404
Aggregate Intrinsic Value, Exercises | $	4,208		6,828
Aggregate Intrinsic Value, Forfeitures | $	0
Aggregate Intrinsic Value, Outstanding ending balance | $	22,563		20,607
Aggregate Intrinsic Value, Nonvested | $	1,640		0
Aggregate Intrinsic Value, Exercisable | $	$ 20,923		$ 20,607
Weighted Average Grant Date Fair Value Per Award, Outstanding beginning balance	$ 4.39	[1]	$ 3.53	[1]
Weighted Average Grant Date Fair Value Per Award, Grants	7.65	[1]
Weighted Average Grant Date Fair Value Per Award, Exercises	2.98	[1]	6.56	[1]
Weighted Average Grant Date Fair Value Per Award, Forfeitures	10.09	[1]
Weighted Average Grant Date Fair Value Per Award, Outstanding ending balance	4.21	[1]	2.78	[1]
Weighted Average Grant Date Fair Value Per Award, Nonvested	9.79	[1]	16.56	[1]
Weighted Average Grant Date Fair Value Per Award, Exercisable	$ 2.85	[1]	$ 2.7	[1]

[1] The Company issued the options with an exercise price per share not less than the closing market price of common stock on the grant date.   The following table presents information related to outstanding options as of December 31, 2025: